Related Experiment Video
Updated: May 3, 2026
11:17
Thoracoscopic Extended Right Middle Plus Lower Sleeve Lobectomy for Non-Small-Cell Lung Cancer
Published on: February 27, 2026
661
[Repeated resection for recurrent pulmonary metastases].
Summary
Repeated lung resections for metastatic cancers can be safe and effective, with a 5-year survival rate of 45.4%. Careful patient selection and experienced surgical teams are crucial for successful outcomes in these complex cases.
Area of Science:
- Thoracic Surgery
- Surgical Oncology
- Pulmonary Medicine
Background:
- Repeated pulmonary resections are common for sarcomas, colorectal cancer, and Grawitz tumors.
- Recurrent pulmonary metastases within six months indicate a poor prognosis.
- Surgical intervention is a key component of comprehensive cancer care.
Purpose of the Study:
- To evaluate the safety and efficacy of repeated pulmonary resections for metastatic lung disease.
- To analyze patient outcomes and survival rates following surgical intervention.
Main Methods:
- A retrospective study of 149 patients undergoing 165 operations between January 1997 and December 2011.
- Analysis of various surgical approaches including muscle-sparing vertical thoracotomy, posterolateral thoracotomy, video-assisted thoracoscopic surgery (VATS), and clamshell thoracotomy.
- Histological data including sarcomas, Grawitz tumors, and laryngeal carcinoma were reviewed.
Main Results:
- The overall 5-year survival rate was 45.4%.
- Complications occurred in 6 cases (3 small air leaks, 3 wound infections), with no need for rethoracotomy.
- Lethality was 0%, and VATS was utilized in 3 cases for extraanatomic resections.
Conclusions:
- Strict patient selection and an experienced multidisciplinary team are vital for successful repeated pulmonary resections.
- Surgical treatment of lung metastases, when performed by specialists, is a safe and beneficial procedure.
- The study highlights the importance of experienced surgical teams in managing complex oncological cases.
